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Materials  
 All chemicals and starting materials were purchased from commercial vendors and used 
as received. Dipyrido[3,2-a:2’,3’-c]phenazine (dppz) was prepared according to the literature.
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UV-Visible spectra were recorded on a Beckman DU 7400 UV-Visible spectrophotometer 
(Beckman Coulter). Oligonucleotides were synthesized using standard phosphoramidite 
chemistry at Integrated DNA Technologies (Coralville, IA) and purified by HPLC using a C18 
reverse-phase column (Varian, Inc.) on a Hewlett-Packard 1100 HPLC. The copper complex 
Cu(phen)2
2+
 was generated in situ by combining CuCl2 with phen ligand in a 1:3 ratio. 
Synthesis  
 Ru(Me4phen)2Cl2: Following a modified literature report,
2
 RuCl3•nH2O (0.217 g, 0.830 
mmol), 3,4,7,8-Tetramethyl-1,10-phenanthroline (0.494 g, 2.09 mmol), and LiCl (0.298 g, 7.03 
mmol) were combined in a Schlenk flask under argon. The contents were dissolved in anhydrous 
DMF (5 mL), and the solution was heated to 140°C and stirred for 4 h while being protected 
from light. The contents were cooled to room temperature, diluted with acetone (20 mL), and 
stored in the freezer overnight. The black precipitate was collected by vacuum filtration, washed 
three times with 5 mL portions of H2O and three times with 5 mL portions of diethyl ether, and 
dried. The product was used subsequently without further purification (0.495 g, 73%).   
 Ru(Me2bpy)2Cl2: RuCl3•nH2O (0.281 g, 1.07 mmol) was reacted with 5,5’-Dimethyl-
2,2’-dipyridine (0.500 g, 2.71 mmol) and LiCl (0.385 g, 9.08 mmol) in DMF (15 mL) under the 
conditions described for the synthesis of Ru(Me4phen)2Cl2. The product was isolated and used 
subsequently without further purification (0.304 g, 63%). 
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[Ru(Me4phen)2dppz]X2 (X = PF6 or Cl): Dppz ligand (0.025 g, 0.089 mmol) was 
combined with Ru(Me4phen)2Cl2 (0.057 g, 0.089 mmol) in ethylene glycol (8 mL) and heated to 
130°C and stirred for 5 h. The reaction was cooled to room temperature and diluted with H2O (8 
mL). Excess NH4PF6 was added to precipitate the product, which was collected by filtration, 
washed copiously with H2O and diethyl ether, and dried. (0.084 g, 82%). ESI(+)MS (m/z): 
[M/2]
+
 found 428.2. The complex was converted to its water-soluble Cl salt by anion exchange 
chromatography (Sephadex QAE) and further purified by preparative HPLC using an isocratic 
method of 65% MeOH and 35% H2O (containing 0.1% TFA) over 60 min. 
1
H NMR (500 MHz, 
DMSO-d6) δ 9.58 (dd, J = 8.2, 1.3 Hz, 2H), 8.54 (dd, J = 6.3, 3.4 Hz, 2H), 8.52 (d, J = 0.9 Hz, 
4H), 8.22 (dd, J = 6.6, 3.4 Hz, 2H), 8.13 (dd, J = 5.4, 1.3 Hz, 2H), 7.90 (m, 4H), 7.76 (s, 2H), 
2.82 (d, J = 1.3 Hz, 12H), 2.27 (d, J = 3.7 Hz, 12H). The complex was again converted to its Cl 
salt by anion exchange chromatography to remove TFA anions present from the HPLC 
purification.  
[Ru(Me2bpy)2dppz]X2 (X = PF6 or Cl): Dppz ligand (0.240 g, 0.851 mmol) was 
combined with Ru(Me2bpy)2Cl2 (0.304 g, 0.563 mmol) in ethylene glycol and reacted as 
described for the Me4phen complex, and the product was collected as its PF6 salt (0.521 g, 
88.8%). ESI(+)MS (m/z): [M/2]
+
 found 376.2. The complex was converted to its water-soluble 
Cl salt by anion exchange chromatography (Sephadex QAE) and further purified by preparative 
HPLC using a gradient of H2O (with 0.1% TFA) to CH3CN over 60 min. 
1
H NMR (500 MHz, 
DMSO-d6) δ 9.62 (dd, J = 8.2, 1.3 Hz, 2H), 8.71 (d, J = 8.4 Hz, 2H), 8.67 (d, J = 8.4 Hz, 2H), 
8.52 (m, 2H), 8.21 (m, 4H), 8.04 (m, 4H), 7.94 (dd, J = 8.4, 1.9 Hz, 2H), 7.54 (dt, J = 1.8, 0.8 
Hz, 2H), 7.48 (dt, J = 1.4, 0.7 Hz, 2H), 2.26 (d, J = 0.7 Hz, 6H), 2.08 (d, J = 0.7 Hz, 6H). The 
 Figure S1: Steady-state luminescence titrations of [Ru(Me4phen)2dppz]
2+
 with well-matched (blue) 
and mismatched (red) DNA. Left plot: samples prepared in 5 mM tris, 50 mM NaCl, pH 7.5. Right 
plot: samples prepared in 5 mM tris, 200 mM NaCl, pH 7.5. [Ru] = 2 µM, λex = 440 nm. Emission 
spectra were integrated from 564-820 nm.  
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complex was again converted to its Cl salt by anion exchange chromatography to remove TFA 
anions present from the HPLC purification. 
Steady-State Luminescence Measurements 
Luminescence spectra were recorded on an ISS-K2 spectrofluorometer at 25°C. The Ru 
complex was excited at 440 nm, and emission spectra were integrated from 564-820 nm. The Cl 
salt of the complex was used for all experiments. In all cases, [DNA] is defined as the 
concentration of full sequence.  
Titrations of [Ru(Me4phen)2dppz]
2+
 with the well-matched and mismatched duplexes 
(Figure S1) were used to determine the binding affinity of the complex for well-matched and 
mismatched sites. For the titration with well-matched DNA, the binding affinity is evaluated 
using the McGhee-Von Hippel method;
3
 a value of 6.75 10
4 
M
-1 
per base pair is obtained with an 
occupational factor, n, of 2.3.  
In order to evaluate the binding affinity of the complex for the mismatched site, we first 
must consider two competing equilibria, expressed below. 
 + 	 ⇌ [_]  
 =	
[_]
[]	[]
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 +	 ⇌ [_] 
 =	
[_]
[]	[]
 
Kass describes the binding equilibrium between the complex, C, and the well-matched base pair 
sites, BP, in the DNA. KMM describes the binding equilibrium between the complex and the 
mismatched site, MM.  
Next, we will express the total concentration of complex as Cc; this is kept constant 
throughout the titration. We can then define the various molar fractions for the complex as 
follows:  
 = 	
[]

, the molar fraction of free complex. 
 = 	
[_]

, the molar fraction of complex bound to WM base pairs. 
 =	
[_]

, the molar fraction of complex bound to MM sites. 
Additionally, we express the total concentration of duplex as CODN; this value increased 
throughout the titration. The variable R is introduced as being equal to the ratio CODN/CC, and in 
our titration the luminescence of the complex is measured as a function of this ratio R. The 
luminescence intensity, I, can be expressed as a function of R as follows:  
 = 	 + 		 
where  and  are equal to the relative emissivity of complex associated with BP and MM, 
respectively.  
We must define two final parameters: x, the the ratio of well-matched sites to mismatched 
sites in the duplex, and p, the occupational factor which takes into account the possible inhibition 
of binding by two complexes in close vicinity. We are now ready to express the equilibrium 
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concentrations of free BP and MM sites as follows:  
[] = 		1 − 	 !" − 	#	[] = 			1 − 	 !" − #		 
[] = 			 !" −	[_] = 				 !" −	 
Thus, 
	
[]

= 		1 − 	$ − #	 and 
[]

= 			$ − 	 
The binding equilibrium equations are thus rewritten as: 

 =	
%
&	'	()*	+),	%
 and 
 =	
-
&	'	*	+)-
 
The expression of b and m as functions of f can thus be obtained: 

			1 − 	$ − #	 −  = 0 
 = 	

 	 		1 − 	$	
1 + 
	 	#	
 

				$ −  −  = 0 
 =	

	 			$	
1 + 
	 	
 
With 
1 =  +  + 
0 =  − 1 +

	 		1 − 	$	
1 + 
	 	#	
+

	 			$	
1 + 
 	 	
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0 =  − 11 + 
	 	#	1 + 
	 	 + 
	 		1 − 	$		1 + 
 	 	
+ 
	 			$	1 + 
 	 	#	 
The expression of the intensity of luminescence, , can be written as follows: 
 = 		

	 		1 − 	$	
1 + 
	 	#	
+ 		

	 			$	
1 + 
 	 	
 
The fitting process is realized by an iterative solving to the expression of f using the previous 
equation. 
A global fitting on the data obtained from the well-matched and mismatched titrations is 
performed (occupational factor set to 2) and yield the values of Kass = 6.8 10
4
 M
-1
 per base pair 
and KMM = 1.8 10
6
 M
-1
 per mismatched site for the 200 mM NaCl condition and Kass = 1.1 10
5
 M
-
1
 per base pair and KMM = 9.7 10
6
 M
-1
 per mismatched site for the 50 mM NaCl condition. The 
errors are evaluated to be equal to 10 %.  
When comparing titrations in 50mM and 200mM NaCl, we observe two changes. First 
for both duplexes, the emission intensities at saturating values for 200mM NaCl are 
approximately half those obtained at 50 mM NaCl, consistent with the increase in ionic strength 
leading to a decrease in emission intensities observed previously. Second we find that the ionic 
strength affects the shape of the binding curve. At 50 mM NaCl we see a maximum emission 
intensity upon titration followed by a decrease in emission as DNA/Ru increases; at 200 mM 
NaCl this effect is less dramatic. We attribute this difference to less non-specific DNA 
association at higher ionic strength. 
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Time-Resolved Luminescence Measurements 
Time-resolved spectroscopic measurements were carried out at the Beckman Institute 
Laser Resource Center, and were conducted using instrumentation that has been described.
4
 
Briefly, a 460 nm light produced by OPO pumped with a 10 Hz, Qswitched Nd:YAG laser 
(Spectra-Physics Quanta-Ray PRO-Series) was used as an excitation source (pump pulse 
duration ≈8 ns). The emitted light was detected at 660 nm with a photomultiplier tube 
(Hamamatsu R928) following wavelength selection by a double monochromator (Instruments 
SA DH-10). Scattered laser light was removed from the detectors using suitable filters. The 
samples were held in 1 cm path length quartz cuvettes (Starna) equipped with stir bars and 
irradiated at 460 nm with 500−1000 laser pulses at 3 mJ/pulse. Kinetic traces were fit to 
exponential equations of the form I(t) = a0 + Σ an exp(−t/τn), where I(t) is the signal intensity as a 
function of time, a0 is the intensity at long time, an is a pre-exponential factor that represents the 
relative contribution from the nth component to the trace, and τn is the lifetime of the nth 
component, convoluted with a Gaussian function to take into account the Instrument Response 
Function (fwmh = 8ns). The errors are evaluated to be equal to 5%, but the incertitude on the 
short component (associated with complexes bond to well-matched DNA, i.e. 33-35 ns) being 
close to the IRF time characteristic is subject to a greater error (+/- 8 ns). 
 
Models of [Ru(Me4phen)2dppz]
2+
 Binding to Well-matched and Mismatched DNA 
The binding constants obtained for the complex with the mismatched and well-matched 
sites indicate that the complex preferentially binds to mismatched DNA. The relative emissivity 
determined during the fitting process, i.e. 40 for complexes associated with well-matched sites 
and 380 for complexes associated with mismatched sites, also correlates with the differential 
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luminescence lifetimes. As such, ruthenium bound to the mismatched site should be more 
protected from quenching than complex bound via intercalation at well-matched sites. To gain 
more insight regarding the local environment around the DNA-bound complex, we used 
published crystal structures
5,6
 of DNA to model the binding of [Ru(Me4phen)2dppz]
2+
. In one 
model, we inserted ∆-[Ru(Me4phen)2dppz]
2+ 
into an AC mismatch via the minor groove (Figure 
4 of main text and Figure S2), and oriented the complex in such a way as to maximize the 
protective environment around the dppz ligand while avoiding steric clashes with the DNA. As 
seen in Figures 4 and S2, the dppz ligand is capable of being deeply inserted into the mismatch 
site, allowing greater protection from quenching. In the other model, we intercalated the complex 
at a well-matched site from the major groove, again minimizing steric clashes between the 
Me4phen ligands and the DNA. In this model, we oriented the complex in both a head-on fashion 
(Figure S2) and a side-on orientation (Figure 4). In the head-on orientation, both phenazine 
nitrogen atoms are relatively well-surrounded by the duplex, but in the side-on approach, we see 
that dppz is more exposed to quenching.  
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Figure S2: Top: Axial views, down the helical axis, of ∆-[Ru(Me4phen)2dppz]
2+  
 modeled into 
the crystal structures of DNA duplexes. Top left: Metalloinsertion at the mismatch site from the 
minor groove; the extruded mismatch bases are shown in orange. Top right: Head-on 
intercalation at a well-matched site from the major groove. Bottom: Side-views of (left) 
metalloinsertion at the mismatch from the minor groove and (right) head-on intercalation at a 
well-matched site from the major groove. The optimization and visualization were carried out 
using UCSF Chimera
 
program. 
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MTT Cytotoxicity Assay 
This assay was performed as described previously.
7 
HCT116N and HCT116O cells were 
plated in 96-well plates (50,000 cells/well), treated with the Ru concentrations indicated in 
Figure 3 of the main text, and incubated for 72 hours (37°C, 5% CO2, humidified atmosphere). 
After this incubation period, MTT was added to the cells (Roche Cell Proliferation Kit I) and the 
cells were incubated for an additional 4 hours. Insoluble formazan crystals were dissolved in 
solubilizing reagent (Roche) over 24 hours (37°C, 5% CO2, humidified atmosphere). The 
solubilized formazan was quantified at 570 nm with 690 nm as the reference wavelength. Percent 
cell viability was calculated as a function of formazan formed in the Ru-treated cells relative to 
untreated cells.  
 
Figure S3: Steady-state NaI quenching of [Ru(Me4phen)2dppz]
2+
 (2 µM) bound to well-matched 
(left, blue) and mismatched (right, red) DNA (2 µM). Solid lines indicate no NaI present, and 
dotted lines represent increasing NaI concentrations of 25, 50, and 75 mM, respectively. λex = 
440 nm. Samples prepared in 5 mM tris, 200 mM NaCl, pH 7.5. The DNA sequences are as in 
Figure 1 of the main text.  
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Figure S4: (Left) Schematic of [Ru(Me2bpy)2dppz]
2+
. (Right) Steady-state luminescence 
titrations of [Ru(Me2bpy)2dppz]
2+
 with well-matched (blue) and mismatched (red) DNA. 
Samples prepared in 5 mM tris, 200 mM NaCl, pH 7.5. [Ru] = 2 µM, λex = 440 nm. Emission 
spectra were integrated from 550-850 nm.  
 
 
 
 
 
Figure S5: Differential cytotoxicity of [Ru(Me4phen)2dppz]
2+
 towards HCT116N and HCT116O 
cell lines. Cells were plated in a 96-well format (5 x 10
4
 cells/well) and treated with the indicated 
Ru concentrations for 72 h. Following this incubation period, the cells were labeled with MTT 
for 4 h. Metabolically active cells reduce the MTT to produce its insoluble formazan, which is 
then solubilized and quantified by its absorbance at 570 nm. The percent viability is the ratio of 
formazan absorbance in cells treated with ruthenium to the absorbance in untreated cells. 
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